scispace - formally typeset
R

Roudayna Diab

Researcher at University of Lorraine

Publications -  22
Citations -  1435

Roudayna Diab is an academic researcher from University of Lorraine. The author has contributed to research in topics: Drug delivery & Prodrug. The author has an hindex of 14, co-authored 22 publications receiving 1115 citations. Previous affiliations of Roudayna Diab include Centre national de la recherche scientifique & Claude Bernard University Lyon 1.

Papers
More filters
Journal ArticleDOI

Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation

Chiraz Jaafar-Maalej, +4 more
- 28 Jul 2010 - 
TL;DR: The elaborated liposomes seem to be promising carriers for both Ara-C and BDP pulmonary delivery, with a significant influence of phospholipid and cholesterol amounts on liposome size and encapsulation efficiency.
Journal ArticleDOI

Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer

Misara Hamoudeh, +3 more
- 15 Sep 2008 - 
TL;DR: This review highlights the use, limitations, advantages and possible improvements of different nano- and microcarriers as potential vehicles for radionuclides delivery in cancer nuclear imaging and radiotherapy.
Journal ArticleDOI

Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.

M. Sala, +3 more
- 15 Jan 2018 - 
TL;DR: An overview of lipid based nanocarriers developed with the aim to enhance dermal and transdermal drug delivery and recent applications of lipid-based nanoccarriers for the management of skin diseases and other illnesses are highlighted.
Journal ArticleDOI

Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them.

Bahman Khameneh, +4 more
- 01 Jun 2016 - 
TL;DR: A wide range of approaches like developing new generations of antibiotics, combination therapy, natural antibacterial substances and applying nanoparticulate systems have been explained, among them, antibiotic delivery via nanoparticles, has been attracted more attention recently, so discussed in present review.
Journal ArticleDOI

Silica-based systems for oral delivery of drugs, macromolecules and cells.

Roudayna Diab, +5 more
- 20 Apr 2017 - 
TL;DR: This review reports the latest advances silica-based systems and discusses the potential benefits and drawbacks of using silica for oral delivery of drugs, macromolecules or cells.